Enhancing chemosensitivity of wild-type and drug-resistant MDA-MB-231 triple-negative breast cancer cell line to doxorubicin by silencing of STAT 3, Notch-1, and β-catenin genes
Arwa Alkaraki(University of Jordan), Abdalla Awidi(University of Jordan), Mamoun Souleiman(University of Jordan), Duaa Abuarqoub(University of Jordan), Walhan Alshaer(Al-Ahliyya Amman University), Lobna Gharaibeh(Al-Ahliyya Amman University), Suha Wehaibi(University of Jordan), Hadil Zureigat(Cleveland Clinic), Dana A. Alqudah(University of Jordan), Hafsa Al-Azzawi(Al-Ahliyya Amman University)
Cited by 43
Related Papers
siRNA: Mechanism of action, challenges, and therapeutic approaches
|European Journal of Pharmacology|2021|428
Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study
|Journal of Orthopaedic Surgery and Research|2017|141
Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy
|CNS Neuroscience & Therapeutics|2017|123